123 related articles for article (PubMed ID: 28174642)
1. Prolonged QT interval and cardiac arrest after a single dose of amiodarone in a woman with Turner's syndrome.
Nielsen DG; Nielsen JC; Trolle C; Gravholt CH; Andersen NH
Clin Case Rep; 2017 Feb; 5(2):154-158. PubMed ID: 28174642
[TBL] [Abstract][Full Text] [Related]
2. Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone.
Mourad A; Stiber JA; Perfect JR; Johnson MD
J Antimicrob Chemother; 2019 Jan; 74(1):228-233. PubMed ID: 30295798
[TBL] [Abstract][Full Text] [Related]
3. Iohexol contrast medium induces QT prolongation in amiodarone patients.
Goernig M; Kirmeier T; Krack A; Hartog CS; Figulla HR; Leder U
Br J Clin Pharmacol; 2004 Jul; 58(1):96-8. PubMed ID: 15206999
[TBL] [Abstract][Full Text] [Related]
4. The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes.
Malik M
Pacing Clin Electrophysiol; 2002 Feb; 25(2):209-16. PubMed ID: 11915990
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
[TBL] [Abstract][Full Text] [Related]
6. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.
Bindraban AN; Rolvink J; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
Int J Clin Pharm; 2018 Oct; 40(5):1372-1379. PubMed ID: 30051227
[TBL] [Abstract][Full Text] [Related]
7. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
[TBL] [Abstract][Full Text] [Related]
8. Sibutramine-associated QT interval prolongation and cardiac arrest.
Ernest D; Gershenzon A; Corallo CE; Nagappan R
Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for QTc interval prolongation.
Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
[TBL] [Abstract][Full Text] [Related]
10. Corrected QT-interval prolongation and variability in intensive care patients.
Hoogstraaten E; Rijkenberg S; van der Voort PH
J Crit Care; 2014 Oct; 29(5):835-9. PubMed ID: 24986247
[TBL] [Abstract][Full Text] [Related]
11. QT prolongation and the antiarrhythmic efficacy of amiodarone.
Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
[TBL] [Abstract][Full Text] [Related]
12. QT prolongation due to aortic aneurysm rupture and amiodarone in a patient with a H558R polymorphism in the cardiac sodium channel gene SCN5A.
Stöllberger C; Steger C; Yilmaz-Kaymaz N; Chen S; Wang Q; Finsterer J
Minerva Cardioangiol; 2006 Aug; 54(4):503-6. PubMed ID: 17016421
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.
Benoit SR; Mendelsohn AB; Nourjah P; Staffa JA; Graham DJ
Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):363-8. PubMed ID: 16079644
[TBL] [Abstract][Full Text] [Related]
14. In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs.
De Bruin ML; Langendijk PN; Koopmans RP; Wilde AA; Leufkens HG; Hoes AW
Br J Clin Pharmacol; 2007 Feb; 63(2):216-23. PubMed ID: 16869820
[TBL] [Abstract][Full Text] [Related]
15. [Combination therapy with fluconazole and other QTc-prolonging drugs increase the QTc interval].
Buch T; Andersen SE
Ugeskr Laeger; 2015 Oct; 177(41):V04150371. PubMed ID: 26471025
[TBL] [Abstract][Full Text] [Related]
16. QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study.
Khan Q; Ismail M; Haider I; Haq IU; Noor S
Eur J Clin Pharmacol; 2017 Nov; 73(11):1511-1518. PubMed ID: 28803378
[TBL] [Abstract][Full Text] [Related]
17. Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.
Malik M
Drug Saf; 2016 Jul; 39(7):647-59. PubMed ID: 26968542
[TBL] [Abstract][Full Text] [Related]
18. Consistency of heart rate-QTc prolongation consistency and sudden cardiac death: The Rotterdam Study.
Niemeijer MN; van den Berg ME; Deckers JW; Franco OH; Hofman A; Kors JA; Stricker BH; Rijnbeek PR; Eijgelsheim M
Heart Rhythm; 2015 Oct; 12(10):2078-85. PubMed ID: 26165945
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic drugs associated with corrected QT interval prolongation.
van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and determinants of QT interval prolongation in medical inpatients.
Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
